Insider Transactions in Q1 2023 at 1 Life Healthcare Inc (ONEM)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2023
|
Lisa A Mango General Counsel and Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
88,385
-100.0%
|
$1,590,930
$18.0 P/Share
|
|
Feb 22
2023
|
Amir Dan Rubin Chair, CEO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
99,748
-100.0%
|
$1,795,464
$18.0 P/Share
|
|
Feb 22
2023
|
Bjorn B Thaler Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,532
-100.0%
|
$387,576
$18.0 P/Share
|
|
Feb 22
2023
|
Vikas Agarwal Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,866
-100.0%
|
$159,588
$18.0 P/Share
|
|
Feb 22
2023
|
Andrew S Diamond Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,620
-100.0%
|
$425,160
$18.0 P/Share
|
|
Feb 22
2023
|
Scott C Taylor |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,753
-100.0%
|
$139,554
$18.0 P/Share
|
|
Feb 22
2023
|
Holmes Kalen |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,534
-100.0%
|
$81,612
$18.0 P/Share
|
|
Feb 22
2023
|
David P Kennedy |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
250,779
-100.0%
|
$4,514,022
$18.0 P/Share
|
|
Feb 22
2023
|
David P Kennedy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,285
-100.0%
|
$185,130
$18.0 P/Share
|
|
Feb 22
2023
|
Freda C Lewis Hall |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,534
-100.0%
|
$81,612
$18.0 P/Share
|
|
Feb 22
2023
|
Mary Ann Tocio |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,298
-100.0%
|
$851,364
$18.0 P/Share
|
|
Feb 22
2023
|
Paul R. Auvil Iii |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,586
-100.0%
|
$226,548
$18.0 P/Share
|
|
Feb 22
2023
|
Mark S. Blumenkranz |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,534
-100.0%
|
$81,612
$18.0 P/Share
|
|
Feb 22
2023
|
Bruce Dunlevie |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
665,257
-100.0%
|
$11,974,626
$18.0 P/Share
|
|
Feb 22
2023
|
Bruce Dunlevie |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,586
-100.0%
|
$226,548
$18.0 P/Share
|
|
Feb 17
2023
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,150
-6.51%
|
$92,250
$15.32 P/Share
|
|
Feb 16
2023
|
Vikas Agarwal Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,117
-19.28%
|
$31,755
$15.36 P/Share
|
|
Feb 16
2023
|
Lisa A Mango General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
7,596
-7.44%
|
$113,940
$15.36 P/Share
|
|
Feb 16
2023
|
Bjorn B Thaler Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,015
-21.84%
|
$90,225
$15.36 P/Share
|
|
Feb 15
2023
|
Vikas Agarwal Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,132
+18.39%
|
-
|
|
Feb 15
2023
|
Andrew S Diamond Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,301
+20.77%
|
-
|
|
Feb 15
2023
|
Lisa A Mango General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
13,746
+6.24%
|
-
|
|
Feb 15
2023
|
Bjorn B Thaler Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,829
+33.42%
|
-
|
|
Jan 15
2023
|
Bruce Dunlevie |
BUY
Grant, award, or other acquisition
|
Direct |
1,051
+7.71%
|
-
|
|
Jan 15
2023
|
Scott C Taylor |
BUY
Grant, award, or other acquisition
|
Direct |
751
+8.83%
|
-
|
|
Jan 15
2023
|
Mary Ann Tocio |
BUY
Grant, award, or other acquisition
|
Direct |
751
+1.56%
|
-
|
|
Jan 15
2023
|
David P Kennedy |
BUY
Grant, award, or other acquisition
|
Direct |
751
+6.81%
|
-
|
|
Jan 15
2023
|
Paul R. Auvil Iii |
BUY
Grant, award, or other acquisition
|
Direct |
1,051
+7.71%
|
-
|